The Cell Biology Core provides Program Project investigators and their supporting staff with technical support and consultation in cell culture development, preparation and experimental design, immunohistochemistry, ELISAs and molecular biology techniques. The Core occupies dedicated laboratory space within the Division of Bone and Mineral Disease at Barnes-Jewish Hospital North. The Cell Biology Core is responsible for the screening and purchasing of serum and the preparation of the various media required to prepare, culture and maintain the numerous cell lines carried in the main laboratory and available for use by the investigators in each project of the Program to carry out their individual experimental protocols. Careful quality control measures have been taken to insure that media and sera are supportive of cell growth and continual attempts made to offer the investigators the """"""""most appropriate, i.e. osteoblastic phenotype, and homogenous cell"""""""" cultures. To continue pursuing the development of techniques and procedures which will ultimately satisfy the continued need for viable bone marrow, phenotypic rat and human osteoblasts and human bone marrow stromal cells and osteoclast-like cells, and multiple cell lines of human and rodent origin, the basic organization of the Core has been expanded. In order to support and service the experimental protocols described in the application which are targeted to: 1) examine bone cell differentiation and communication via cell adhesion; 2) examine the control of osteoclast activation and differentiation; 3) examine cell matrix response to mechanical loading; and 4) examine osteoclast-mediated bone remodeling, new technical support is proposed for the present renewal. To accomplish this goal, we plan new endeavors in the Cell Biology Core including technical support in the areas of: (1) immunohistochemical analysis of osteoblast development, expression of specific membrane proteins and osteoclast function; (2) analysis of cell culture supernatants for cytokines by ELISA; (3) providing services for the development, preparation and/or maintenance of new cell lines, and 4) providing a centralized area for molecular biology procedure. Based on current and projected usage, we expect that the Core resources will be extensive utilized nd that demands for our services to grow.

Project Start
2000-07-01
Project End
2001-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
18
Fiscal Year
2000
Total Cost
$245,840
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Collin-Osdoby, Patricia; Osdoby, Philip (2012) RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Biol 816:187-202
Lai, Chung-Fang; Bai, Shuting; Uthgenannt, Brian A et al. (2006) Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. J Bone Miner Res 21:17-28
Lai, Chung-Fang; Cheng, Su-Li (2005) Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 20:330-40
Mbalaviele, Gabriel; Sheikh, Sharmin; Stains, Joseph P et al. (2005) Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 94:403-18
Wright, Lorinda M; Maloney, William; Yu, Xuefeng et al. (2005) Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36:840-53
Yu, Xuefeng; Huang, Yuefang; Collin-Osdoby, Patricia et al. (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19:2065-77
Castro, Charlles H M; Shin, Chan Soo; Stains, Joseph P et al. (2004) Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J Cell Sci 117:2853-64
Collin-Osdoby, Patricia; Yu, Xuefeng; Zheng, Hong et al. (2003) RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Med 80:153-66
Cheng, Su-Li; Shao, Jian-Su; Charlton-Kachigian, Nichole et al. (2003) MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278:45969-77
Rifas, Leonard; Arackal, Sophia (2003) T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 48:993-1001

Showing the most recent 10 out of 119 publications